Arcutis Biotherapeutics, Inc. ARQT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s operating cash flow?
- Arcutis Biotherapeutics, Inc. (ARQT) reported operating cash flow of $2.24M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s operating cash flow changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s operating cash flow increased by 107.4% year-over-year, from -$30.38M to $2.24M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s operating cash flow?
- Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s operating cash flow has grown at a -13.7% compound annual growth rate (CAGR), from -$174.63M to -$112.16M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.